MadBee511
$STPDF Readers: if you are an IP investor interested in Genoptic, this may be worth reading and sharing.
I rarely give advice on any ticker I hold or have held. Some of my followers know my Asymmetric Validation Model (AVM).
Genoptic came onto my radar through a casual meeting at my local sports centre. I was given a personal pitch deck during a coffee meeting with Darryl Copeland, Business Development Lead at Genoptic LED Inc.
Disclosure: I am not compensated by Genoptic and I currently hold no shares. I’ll explain why.
Genoptic is currently at the late-Seed / pre-Series A stage and describes its current financing as a US$5M Seed round. That's outside my investment range, so I’m not participating.
But sharing is caring.
Genoptic reports 151 IP assets across 24 patent families. If that doesn't interest you, simply move on. If it does, the DD may be worth your time.